Can methylphenidate objectively provide relief in patients with uncontrolled blepharospasm? A pilot study using...

Area of Science:

• Ophthalmology
• Neurology
• Pharmacology

Background:

• Benign essential blepharospasm (BEB) is a neurological disorder causing involuntary eyelid closure.
• Current treatments like botulinum toxin injections provide temporary relief.
• The potential role of medications like Ritalin in managing BEB symptoms requires further investigation.

Purpose of the Study:

• To investigate the objective benefits of prescribing Ritalin for patients experiencing uncontrolled blepharospasm.
• To assess Ritalin's impact on muscle activity and functional disability in BEB patients.

Main Methods:

• A pilot study involving seven subjects with BEB undergoing botulinum toxin treatment.
• Ritalin LA was administered during the symptomatic return period.
• Surface electromyography (sEMG) and a functional disability scale were used to measure outcomes before and after Ritalin administration.

Main Results:

• Ritalin administration led to a significant decrease in mean sEMG voltage in 13 of 14 eyes.
• The right eye showed a 50% voltage decrease, and the left eye showed a 31% decrease.
• Functional Disability Scores significantly improved post-Ritalin administration.

Conclusions:

• Ritalin demonstrated a significant reduction in muscle activity and subjective functional disability in this preselected BEB patient group.
• These findings suggest a potential benefit of Ritalin for BEB during symptomatic periods.
• A randomized, controlled trial is recommended to confirm Ritalin's efficacy compared to placebo for BEB.